Veravas
Austin
About Veravas
Veravas develops proprietary sample pretreatment products and new diagnostic tests to provide laboratories with high-value solutions for the accurate diagnoses of some of the world’s most devastating diseases. The company is also building new strategic collaborative partnerships to bring other diagnostic applications to the clinical in vitro diagnostics market. Its proprietary sample preparation technology uses nanomagnetic beads that can be added to patient test samples. This core technology enables capture of specific substances for removal and to concentrate and quantify those factors for improved measurement of complex biomarkers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Last round: Convertible Note (Feb 2020)
- Website: veravas.com
- Phone: 1.888.466.4166
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/veravas-61342 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.